Ronald Loucks, DPM
Foot Surgery · Festus, MONPI 1316946940
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,176 of the $4,413 with a category attached, or 72.0%. 4 manufacturers reported payments, led by Stryker at 53.1% of the total.
Across 47 payments — averaging $93.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Treace Medical Concepts, Inc.$2K
- Medartis Inc.$268
- Medline Industries LP$35
What the payments were for
- Travel & lodging$3,17672%
- Food & beverage$1,23728%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 35 | $2,343 |
| Treace Medical Concepts, Inc. | 10 | $1,767 |
| Medartis Inc. | 1 | $268 |
| Medline Industries LP | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,457
- ORTHOLOC 2 LAPIFUSE$595
- CITREFIX$548
- AUGMENT INJECTABLE$288
- APTUS$268
- ORTHOLOC 3DI$220
How this compares
$4,413 in reported general payments places this provider in the 70th percentile of 21 foot surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 140 | $1,295 |
| Duloxetine Hcl | 53 | $690 |
| Pregabalin | 47 | $671 |
| Terbinafine Hcl | 79 | $631 |
| Cephalexin | 18 | $561 |
| Clobetasol Propionate | 23 | $532 |
| Allopurinol | 48 | $300 |
| Naproxen | 25 | $245 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $235 |
| Doxycycline Hyclate | 15 | $169 |
| Ciprofloxacin Hcl | 21 | $136 |
| Meloxicam | 45 | $121 |
| Prednisone | 25 | $97 |
| SsdSilver Sulfadiazine | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Festus
- Michael YankowitzFestus$271
- Jody McAleerJefferson City$3.6M
- Akilis TheoharidisGladstone$100K
- Mark SeidenSpringfield$20K
- Stephen PalmerKansas City$10K
- Robert BondiLees Summit$10K
- Laurel BondiLees Summit$5K
- Thomas HewittGladstone$2K
- Joel FosterLee's Summit$2K
- Anthony SikoutrisSedalia$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.